Os Therapies Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.36

+0.09 (+7.09%)

As of Feb 8, 2:18 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +2,294.9% upside

Low Target $26.16

Average Target $32.57

High Target $50.99

Current Price $1.36

Current
$1.36

Target
$32.57

$26.16 $32.57 avg $50.99

Scenario Analysis

Bear Case

$26.16

1,823.5%

Low target

Base Case

$32.57

+2,294.9%

Avg target

Bull Case

$50.99

+3,649.3%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$39.83

-96.6% from high

52-Week Low

$19.87

+-93.2% from low

Target vs 52W High

$32.57

-18.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%